Clinical trial Recruiting at 1 site Interventional Ages 18 to 40

Effects of red light therapy on eye structures in myopic adults

Official title: The Short-term Impact of Different Types of Red Light Therapy on Choroid and Retina

Run by The Hong Kong Polytechnic University · NCT06753773 · Data updated 2026-11-12

This study is testing different red light therapy techniques to see how they affect the eye structures of young adults with nearsightedness.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexAll
Enrollment60 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedDecember 22, 2024
Main results expectedSeptember 30, 2025
Study endsSeptember 30, 2025
Registry record updatedDecember 31, 2024
Trial IDNCT06753773 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 40 with myopia between -1.00D and -6.00D and a best corrected visual acuity of 20/20 or better.

Probably not a fit

Patients with significant ocular or systemic diseases, or those who have undergone similar therapies recently, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research project is a randomized controlled trial that investigates the short-term effects of different red light therapy techniques on the choroidal and retinal structures in adults with myopia. The study will enroll 45 participants aged 18 to 40, who will be assigned to one of three groups based on the size and shape of the light spots used during therapy. The primary goal is to identify which retinal regions are most affected by low-level red light therapy, while also assessing the safety of these interventions. Participants will undergo repeated treatments to evaluate potential choroidal thickening.

Why it matters

Potential benefit: If successful, this study could lead to new therapeutic options for managing myopia and improving eye health.

How similar studies have gone: While the specific application of red light therapy for myopia is relatively novel, similar approaches in other ocular conditions have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age: 18 to 40 years.
2. Myopic spherical equivalent refraction (SER) between -1.00D to -6.00D in both eyes.
3. Best corrected visual acuity (BCVA): 20/20 or greater.
4. Informed consent for participation.

Exclusion Criteria:

1. Anisometropia greater than 1.50D.
2. Ophthalmic diseases other than refractive errors, including but not limited to strabismus and binocular vision abnormalities in either eye.
3. Systemic diseases (e.g., endocrine, cardiac diseases) and developmental abnormalities.
4. Inability to attend regular follow up assessment.
5. Undergo RLRL therapy in the past 6 months
6. Contraindications to RLRL therapy.

Where it's running

  • The Hong Kong Polytechnic University
    Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.